Skip to main content
SpringerLink
Log in

Herpes zoster vaccine live: no increase in serious AEs

  • Epidemiology clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Mbinta JF, et al. Herpes zoster vaccine safety in the Aotearoa New Zealand population: a self-controlled case series study Nature Communications : 19 Jul 2023. Available from: URL: https://doi.org/10.1038/s41467-023-39595-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Herpes zoster vaccine live: no increase in serious AEs. Reactions Weekly 1967, 7 (2023). https://doi.org/10.1007/s40278-023-43814-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-43814-9

Search

Navigation